ITGAM and neoplasm: The application of tarin as an adjuvant molecule to minimize CY effects should be considered in tumor-bearing mice models since tumor environments stimulate the abnormal development of Gr1+CD11b+ myeloid cells, giving rise to a myeloid-derived suppressor cell (MDSC) population.